| Literature DB >> 34930533 |
Emily Kim1, Marie-Pierre Létourneau-Montminy2, William Lambert3, Tristan Chalvon-Demersay3, Elijah G Kiarie4.
Abstract
Eimeria infections impair digestive tract capacity and barrier function leading to poor growth and feed efficiency. A meta-analysis approach was used to evaluate and quantify impact of Eimeria infection on the apparent ileal digestibility (AID) of amino acids (AA) in broiler chickens. A database composed of 6 articles with a total of 21 experiments was built for the effect of challenge type (a mix of Eimeria spp. vs. E. acervulina) and subdatabase of 3 articles with a total of 15 experiments for the effect of E. acervulina dose response. Regression models were fitted with the mixed model procedure in Minitab 19 with fixed effects of challenge, species, and their interactions. For the sub database, the mixed model procedure was used to fit regression models and identify a linear or quadratic response to dose. Challenge decreased AID (P < 0.05) of both dispensable and indispensable AA except for Trp. Specifically, the largest depression was observed for Cys, Thr, Tyr, Ala, and Val with the magnitude of difference of 8.7, 5.4, 5.2, 5.1, and 4.9%, respectively for challenged vs. unchallenged birds. The type of challenge affected (P < 0.05) AID of AA with exception of Cys, Tyr, Ala, Ser, Leu, Asp, Gly, and Pro. E. acervulina challenge had larger negative effects on AID of Ile, Leu, and Val. Moreover, E. acervulina linearly decreased (P < 0.05) AID of all indispensable and dispensable AA except for Trp and quadratically (P < 0.05) decreased AID of all AA except Cys, Met, Arg, and Trp. The largest linear decrease due to E. acervulina dose was seen for AID of Cys, followed by Ala, Val, Thr, and Ile. Although, AID of Trp was not affected by E. acervulina challenge, mixed Eimeria species challenge decreased (P < 0.05) AID of Trp. Overall, the results confirmed that an Eimeria infection negatively impacted AA digestibility/utilization. The ranking of the most affected AA suggested ground for nutritional intervention during subclinical field Eimeria infections or vaccination programs.Entities:
Keywords: Eimeria challenge; amino acids digestibility; broiler chickens; meta-analysis
Mesh:
Substances:
Year: 2021 PMID: 34930533 PMCID: PMC8713024 DOI: 10.1016/j.psj.2021.101625
Source DB: PubMed Journal: Poult Sci ISSN: 0032-5791 Impact factor: 3.352
List of comparison studies used in meta-analysis.
| Publication | Objective | Bird breed | Challenge code | Challenge type | Concentration of oocysts | Challenge duration |
|---|---|---|---|---|---|---|
| 1 | Ross 308 | 0 | 0.00 | 6 | ||
| 1 | Ross 308 | 1 | 2.50 | 6 | ||
| 1 | Ross 308 | 1 | 5.00 | 6 | ||
| 1 | Ross 308 | 1 | 10.00 | 6 | ||
| 2 | Age | Ross 708 | 0 | mix | 0.00 | 6 |
| 2 | Age | Ross 708 | 1 | mix | 0.06 | 6 |
| 3 | Cu supplementation and AA level | Ross 308 | 0 | 0.00 | 15 | |
| 3 | Cu supplementation and AA level | Ross 308 | 1 | 6.33 | 15 | |
| 4 | Diet type and vaccination type | Cobb 500 | 0 | mix | 0.00 | 12 |
| 4 | Diet type and vaccination type | Cobb 500 | 1 | mix | 0.0489 | 12 |
| 5 | Ross 308 | 0 | mix | 0.00 | 10 | |
| 5 | Ross 308 | 1 | mix | 0.0383 | 10 |
Publications: Adedokun et al. (2016), Rochell et al. (2016a), Rochell et al. (2016b), Gautier and Rochell (2020).
Challenge code (0 = not challenged, 1 = challenged).
Challenge type mix species consist of E. acervulina, E. maxima, E. mivati, E. tenella.
Concentration of oocysts (1.0 × 105/mL).
Measured in days.
Descriptive statistics of databases.
| AID | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Database | Overall | |||||||||
| No. of experiments | 13 | 7 | ||||||||
| No. of treatments | 26 | 14 | ||||||||
| Independent variable | n | Mean | SD | Min | Max | n | Mean | SD | Min | Max |
| Challenge | 26 | 14 | ||||||||
| Challenge type | 26 | 14 | ||||||||
| Oocyst concentration | 26 | 1.66 | 2.97 | 0.00 | 10.00 | 14 | 3.06 | 3.51 | 0.00 | 10.00 |
| Dependent variable | ||||||||||
| Digestibility, % | ||||||||||
| Arg | 26 | 86.73 | 3.84 | 71.50 | 90.80 | 14 | 88.23 | 2.54 | 82.40 | 90.80 |
| His | 26 | 81.80 | 5.56 | 58.80 | 86.50 | 14 | 83.92 | 2.88 | 77.30 | 86.50 |
| Ile | 26 | 79.73 | 5.77 | 57.10 | 85.20 | 14 | 81.55 | 4.16 | 72.90 | 85.20 |
| Leu | 26 | 81.68 | 5.15 | 63.10 | 87.20 | 14 | 83.40 | 4.22 | 74.30 | 87.20 |
| Lys | 26 | 83.79 | 3.52 | 73.00 | 88.30 | 14 | 85.26 | 3.13 | 78.40 | 88.30 |
| Met | 26 | 89.39 | 3.08 | 81.10 | 93.60 | 14 | 90.51 | 3.09 | 85.40 | 93.60 |
| Phe | 26 | 80.78 | 6.38 | 56.00 | 87.30 | 14 | 83.42 | 4.00 | 75.10 | 87.30 |
| Thr | 26 | 73.73 | 6.31 | 49.50 | 79.80 | 14 | 76.01 | 4.16 | 67.10 | 79.80 |
| Trp | 20 | 82.28 | 10.96 | 56.90 | 90.10 | 14 | 88.81 | 0.93 | 87.10 | 90.10 |
| Val | 26 | 77.93 | 6.13 | 53.80 | 84.00 | 14 | 80.12 | 4.32 | 71.10 | 84.00 |
| Ala | 26 | 79.84 | 5.97 | 57.60 | 86.00 | 14 | 81.70 | 4.53 | 72.20 | 86.00 |
| Asp | 26 | 77.69 | 5.37 | 56.90 | 82.90 | 14 | 79.29 | 3.65 | 71.30 | 82.90 |
| Cys | 26 | 66.34 | 8.42 | 43.40 | 75.40 | 14 | 66.24 | 8.46 | 44.10 | 73.20 |
| Glu | 26 | 84.90 | 4.55 | 68.40 | 89.40 | 14 | 86.41 | 3.31 | 79.20 | 89.40 |
| Gly | 26 | 74.83 | 5.36 | 53.80 | 80.00 | 14 | 75.56 | 3.51 | 68.20 | 80.00 |
| Pro | 26 | 80.06 | 5.52 | 58.10 | 85.00 | 14 | 81.54 | 3.93 | 72.60 | 85.00 |
| Ser | 26 | 77.34 | 5.69 | 55.10 | 83.00 | 14 | 79.06 | 3.86 | 70.90 | 83.00 |
| Tyr | 16 | 82.67 | 3.12 | 76.20 | 86.60 | 14 | 82.98 | 3.13 | 76.20 | 86.60 |
Abbreviations: Ala, alanine; Asp, aspartic acid; Arg, arginine; Cys, cysteine; Glu, glutamic acid; Gly, glycine; His, histidine; Ile, isoleucine; Leu, leucine; Lys, lysine; Met, methionine; n, number of studies; Phe, phenylalanine; Pro, proline; Ser, serine; Thr, threonine; Trp, tryptophan; Tyr, tyrosine; Val, valine.
Publications: Adedokun et al. (2016), Rochell et al. (2016a), Rochell et al. (2016b), Gautier and Rochell (2020).
Overall database contained all studies.
Acervulina database contained studies with just E. acervulina challenge.
Impact of challenge and challenge type on apparent ileal amino acid digestibility.
| AID | |||||||
|---|---|---|---|---|---|---|---|
| Amino acid | Regression equation | Intercept | Challenge | Challenge type | Challenge × Challenge type | RMSE | R2, % |
| Arg | y=87.30+1.11a+0.90b+0.66c | <0.001 | 0.003 | 0.013 | 0.060 | 1.60 | 55.89 |
| His | y=82.70+1.49a+1.20b+0.53c | <0.001 | 0.004 | 0.017 | 0.264 | 2.22 | 50.41 |
| Ile | y=80.70+1.89a+0.84b+1.09c | <0.001 | 0.002 | 0.117 | 0.046 | 2.49 | 54.39 |
| Leu | y=82.42+1.78a+0.98b+1.17c | <0.001 | 0.004 | 0.087 | 0.044 | 2.63 | 51.73 |
| Lys | y=84.06+1.56a+1.20b+0.72c | <0.001 | 0.001 | 0.007 | 0.085 | 1.92 | 60.56 |
| Met | y=89.52+1.10a+0.99b+0.54c | <0.001 | 0.027 | 0.045 | 0.255 | 2.24 | 38.94 |
| Phe | y=81.86+1.7a+1.56b+1.05c | <0.001 | 0.003 | 0.008 | 0.061 | 2.56 | 57.00 |
| Thr | y=74.73+2.07a+1.27b+0.90c | <0.001 | 0.000 | 0.049 | 0.155 | 2.95 | 50.18 |
| Trp | y=79.14+1.36a+9.66b-1.65c | <0.001 | 0.136 | 0.000 | 0.075 | 3.02 | 90.37 |
| Val | y=78.89+2.01a+1.22b+1.12c | <0.001 | 0.001 | 0.031 | 0.045 | 2.54 | 58.23 |
| Ala | y=80.75+2.12a+0.95b+1.19c | <0.001 | 0.002 | 0.134 | 0.064 | 2.94 | 51.43 |
| Asp | y=78.65+1.69a+0.63b+0.90c | <0.001 | 0.004 | 0.240 | 0.100 | 2.52 | 46.41 |
| Cys | y=67.48+3.07a-1.24b+2.03c | <0.001 | 0.031 | 0.358 | 0.140 | 6.38 | 33.58 |
| Glu | y=85.55+1.45a+0.86b+0.85c | <0.001 | 0.012 | 0.117 | 0.120 | 2.54 | 42.33 |
| Gly | y=75.72+1.44a+0.85b+0.93c | <0.001 | 0.017 | 0.139 | 0.107 | 2.66 | 40.86 |
| Pro | y=81.03+1.45a+0.51b+1.07c | <0.001 | 0.017 | 0.371 | 0.067 | 2.68 | 40.22 |
| Ser | y=78.37+1.83a+0.69b+1.00c | <0.001 | 0.002 | 0.192 | 0.066 | 2.49 | 51.30 |
| Tyr | y=81.76+2.19a+1.22b+0.14c | <0.001 | 0.016 | 0.143 | 0.857 | 2.06 | 65.16 |
Abbreviations: Ala, alanine; Asp, aspartic acid; Arg, arginine; Cys, cysteine; Glu, glutamic acid; Gly, glycine; His, histidine; Ile, isoleucine; Leu, leucine; Lys, lysine; Met, methionine; Phe, phenylalanine; Pro, proline; Ser, serine; Thr, threonine; Trp, tryptophan; Tyr, tyrosine; Val, valine.
y = apparent ileal amino acid digestibility (%).
a = effect of challenge (1 = not challenged, -1 = challenged).
b = effect of challenge type (1 = acervulina, -1 = mix).
c = effect of challenge × challenge type (1 = acervulina not challenged, mix challenged, -1 = acervulina challenged, mix not challenged.
Figure 1Impact of challenge and challenge type on apparent ileal amino acid digestibility of indispensable amino acids. Abbreviations: Arg, arginine; His, histidine; Ile, isoleucine; Leu, leucine; Lys, lysine; Met, methionine; Phe, phenylalanine; Thr, threonine; Trp, tryptophan; Val, valine. * = effect of challenge, P < 0.05. ** = effect of challenge type (E. acervulina vs. mix), P < 0.05. *** = effect of challenge and challenge type interaction, P < 0.05.
Figure 2Impact of challenge and challenge type on apparent ileal amino acid digestibility of dispensable amino acids. Abbreviations: Ala, alanine, Asp, aspartic acid; Cys, cysteine; Glu, glutamic acid; Gly, glycine; Pro, proline; Ser, serine; Tyr, tyrosine. * = effect of challenge, P < 0.05. ** = effect of challenge type (E. acervulina vs. mix), P < 0.05. *** = effect of challenge and challenge type interaction, P < 0.05.
Ranking of amino acid digestibility affected by challenge.
| Amino acid | Rank |
|---|---|
| Cys | 1 |
| Arg | 2 |
| Met | 3 |
| Ala | 4 |
| Tyr | 5 |
| Thr | 6 |
| Val | 7 |
| Gly | 8 |
| Lys | 9 |
| Ile | 10 |
| His | 11 |
| Glu | 12 |
| Pro | 13 |
| Ser | 14 |
| Phe | 15 |
| Asp | 16 |
| Trp | 17 |
| Leu | 18 |
Abbreviations: Ala, alanine; Asp, aspartic acid; Arg, arginine; Cys, cysteine; Glu, glutamic acid; Gly, glycine; His, histidine; Ile, isoleucine; Leu, leucine; Lys, lysine; Met, methionine; Phe, phenylalanine; Pro, proline; Ser, serine; Thr, threonine; Trp, tryptophan; Tyr, tyrosine; Val, valine.
Ranking from most affected by challenge to least affected.
Impact of oocyst concentration on apparent ileal amino acid digestibility.
| AID | ||||||
|---|---|---|---|---|---|---|
| Amino acid | Regression equation | Intercept | Linear | Quadratic | RMSE | R2, % |
| Arg | y=90.14-1.38x+0.11x2 | 0.000 | 0.007 | 0.051 | 1.29 | 83.29 |
| His | y=86.09-1.61x+0.13x2 | 0.000 | 0.005 | 0.035 | 1.36 | 86.50 |
| Ile | y=84.75-2.29x+0.18x2 | 0.000 | 0.004 | 0.035 | 1.88 | 87.64 |
| Leu | y=86.56-2.25x+0.18x2 | 0.000 | 0.006 | 0.046 | 1.93 | 87.78 |
| Lys | y=87.68-1.69x+0.13x2 | 0.000 | 0.003 | 0.035 | 1.31 | 89.85 |
| Met | y=92.24-1.19x+0.09x2 | 0.000 | 0.032 | 0.155 | 1.37 | 90.72 |
| Phe | y=86.44-2.16x+0.17x2 | 0.000 | 0.005 | 0.042 | 1.83 | 87.57 |
| Thr | y=79.17-2.30x+0.19x2 | 0.000 | 0.003 | 0.030 | 1.80 | 89.22 |
| Trp | y=88.54-0.03x+0.02x2 | 0.000 | 0.822 | 0.333 | 0.39 | 92.46 |
| Val | y=83.48-2.42x+0.19x2 | 0.000 | 0.003 | 0.031 | 1.95 | 87.44 |
| Ala | y=85.23-2.46x+0.19x2 | 0.000 | 0.004 | 0.037 | 1.99 | 88.31 |
| Asp | y=82.08-2.04x+0.16x2 | 0.000 | 0.004 | 0.035 | 1.71 | 86.39 |
| Cys | y=71.69-4.00x+0.33x2 | 0.000 | 0.019 | 0.096 | 4.23 | 86.58 |
| Glu | y=88.89-1.78x+0.14x2 | 0.000 | 0.006 | 0.050 | 1.60 | 85.82 |
| Gly | y=79.14-1.94x+0.16x2 | 0.000 | 0.008 | 0.049 | 1.86 | 81.93 |
| Pro | y=84.27-2.02x+0.16x2 | 0.000 | 0.010 | 0.062 | 1.90 | 86.90 |
| Ser | y=82.09-2.21x+0.18x2 | 0.000 | 0.002 | 0.022 | 1.65 | 88.99 |
| Tyr | y=85.48-1.80x+0.14x2 | 0.000 | 0.003 | 0.027 | 1.47 | 85.00 |
Abbreviations: Ala, alanine; Asp, aspartic acid; Arg, arginine; Cys, cysteine; Glu, glutamic acid; Gly, glycine; His, histidine; Ile, isoleucine; Leu, leucine; Lys, lysine; Met, methionine; Phe, phenylalanine; Pro, proline; Ser, serine; Thr, threonine; Trp, tryptophan; Tyr, tyrosine; Val, valine
y = apparent ileal amino acid digestibility (%).
x = oocyst concentration (1.0 × 105/mL).
Figure 3Oocyst concentration1 effect on apparent ileal amino acid digestibility. Abbreviations: Ala, alanine; Arg, arginine; Asp, aspartic acid; Cys, cysteine; Glu, glutamic acid; Gly, glycine; His, histidine; Ile, isoleucine; Leu, leucine; Lys, lysine; Met, methionine; Phe, phenylalanine; Pro, proline; Ser, serine; Thr, threonine; Trp, tryptophan; Tyr, tyrosine; Val, valine. 1 oocyst concentration (1.0 × 105/mL).